Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Copper pathology in vulnerable brain regions in Parkinson's disease.

Davies KM, Bohic S, Carmona A, Ortega R, Cottam V, Hare DJ, Finberg JP, Reyes S, Halliday GM, Mercer JF, Double KL.

Neurobiol Aging. 2014 Apr;35(4):858-66. doi: 10.1016/j.neurobiolaging.2013.09.034. Epub 2013 Oct 2.

PMID:
24176624
2.

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.

Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, Giaveri G, Arosio P, Santambrogio P, Fariello RG, Karatekin E, Kleinman MH, Turro N, Hornykiewicz O, Zucca FA.

Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9843-8. Epub 2004 Jun 21.

3.

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.

Brain. 2005 Nov;128(Pt 11):2654-64. Epub 2005 Jul 6.

4.

Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.

Jellinger KA.

Acta Neuropathol. 2003 Sep;106(3):191-201. Epub 2003 Jul 5. Erratum in: Acta Neuropathol (Berl). 2003 Dec;106(6):588.

PMID:
12845452
5.

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.

Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y.

Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.

7.

Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.

Gründemann J, Schlaudraff F, Haeckel O, Liss B.

Nucleic Acids Res. 2008 Apr;36(7):e38. doi: 10.1093/nar/gkn084. Epub 2008 Mar 10.

8.

Alteration in alpha-synuclein mRNA expression in Parkinson's disease.

Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ.

Mov Disord. 2004 Feb;19(2):162-70.

PMID:
14978671
10.

Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease.

Botella JA, Bayersdorfer F, Schneuwly S.

Neurobiol Dis. 2008 Apr;30(1):65-73. doi: 10.1016/j.nbd.2007.11.013. Epub 2008 Jan 3.

PMID:
18243716
11.

Study of Cu chemical state inside single neurons from Parkinson's disease and control substantia nigra using the micro-XANES technique.

Chwiej J, Adamek D, Szczerbowska-Boruchowska M, Krygowska-Wajs A, Bohic S, Lankosz M.

J Trace Elem Med Biol. 2008;22(3):183-8. doi: 10.1016/j.jtemb.2008.03.006. Epub 2008 Jun 26.

PMID:
18755393
12.

Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra.

Mori F, Nishie M, Kakita A, Yoshimoto M, Takahashi H, Wakabayashi K.

J Neuropathol Exp Neurol. 2006 Aug;65(8):808-15.

13.

Nurr1 in Parkinson's disease and related disorders.

Chu Y, Le W, Kompoliti K, Jankovic J, Mufson EJ, Kordower JH.

J Comp Neurol. 2006 Jan 20;494(3):495-514.

14.

[Lewy body formation in Parkinson's disease: neurodegeneration or neuroprotection?].

Wakabayashi K.

Rinsho Shinkeigaku. 2008 Nov;48(11):981-3. Review. Japanese.

PMID:
19198138
15.

Copper and copper proteins in Parkinson's disease.

Montes S, Rivera-Mancia S, Diaz-Ruiz A, Tristan-Lopez L, Rios C.

Oxid Med Cell Longev. 2014;2014:147251. doi: 10.1155/2014/147251. Epub 2014 Jan 8. Review.

16.

Complex network-driven view of genomic mechanisms underlying Parkinson's disease: analyses in dorsal motor vagal nucleus, locus coeruleus, and substantia nigra.

Corradini BR, Iamashita P, Tampellini E, Farfel JM, Grinberg LT, Moreira-Filho CA.

Biomed Res Int. 2014;2014:543673. doi: 10.1155/2014/543673. Epub 2014 Nov 26.

17.

Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.

Ferrer I, Perez E, Dalfó E, Barrachina M.

Neurosci Lett. 2007 Mar 30;415(3):205-9. Epub 2007 Jan 14.

PMID:
17284347
18.
19.

Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease.

Neystat M, Lynch T, Przedborski S, Kholodilov N, Rzhetskaya M, Burke RE.

Mov Disord. 1999 May;14(3):417-22.

PMID:
10348463
20.

Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.

Reimão S, Pita Lobo P, Neutel D, Correia Guedes L, Coelho M, Rosa MM, Ferreira J, Abreu D, Gonçalves N, Morgado C, Nunes RG, Campos J, Ferreira JJ.

Eur J Neurol. 2015 Mar;22(3):540-6. doi: 10.1111/ene.12613. Epub 2014 Dec 22.

PMID:
25534480
Items per page

Supplemental Content

Write to the Help Desk